INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 75 filers reported holding INOVIO PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 3.88 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $79,306 | -47.4% | 96,715 | 0.0% | 0.00% | – |
| Q4 2022 | $150,875 | -1.2% | 96,715 | +9.3% | 0.00% | – |
| Q3 2022 | $152,687 | -2.5% | 88,514 | -2.2% | 0.00% | – |
| Q2 2022 | $156,530 | -48.8% | 90,480 | +6.2% | 0.00% | – |
| Q1 2022 | $305,767 | -42.0% | 85,172 | -19.4% | 0.00% | – |
| Q4 2021 | $527,000 | -31.3% | 105,690 | -1.3% | 0.00% | -100.0% |
| Q3 2021 | $767,000 | -28.4% | 107,096 | -7.3% | 0.00% | 0.0% |
| Q2 2021 | $1,071,000 | +11.3% | 115,498 | +11.4% | 0.00% | 0.0% |
| Q1 2021 | $962,000 | +14.5% | 103,642 | +9.1% | 0.00% | 0.0% |
| Q4 2020 | $840,000 | -19.1% | 94,965 | +6.1% | 0.00% | 0.0% |
| Q3 2020 | $1,038,000 | -61.4% | 89,478 | +5.4% | 0.00% | -66.7% |
| Q2 2020 | $2,690,000 | +482.3% | 84,889 | +36.8% | 0.00% | +200.0% |
| Q1 2020 | $462,000 | +125.4% | 62,050 | +0.1% | 0.00% | – |
| Q4 2019 | $205,000 | +55.3% | 62,007 | -0.9% | 0.00% | – |
| Q3 2019 | $132,000 | -28.3% | 62,553 | 0.0% | 0.00% | – |
| Q2 2019 | $184,000 | -18.6% | 62,553 | +3.6% | 0.00% | – |
| Q1 2019 | $226,000 | +4.6% | 60,404 | +12.1% | 0.00% | – |
| Q4 2018 | $216,000 | -33.5% | 53,880 | -7.8% | 0.00% | – |
| Q3 2018 | $325,000 | +21.7% | 58,418 | -14.0% | 0.00% | – |
| Q2 2018 | $267,000 | -12.5% | 67,916 | +4.8% | 0.00% | – |
| Q1 2018 | $305,000 | +13.4% | 64,835 | -0.8% | 0.00% | – |
| Q4 2017 | $269,000 | -33.4% | 65,360 | +2.5% | 0.00% | – |
| Q3 2017 | $404,000 | -5.6% | 63,783 | +16.7% | 0.00% | -100.0% |
| Q2 2017 | $428,000 | +20.2% | 54,670 | +1.7% | 0.00% | – |
| Q1 2017 | $356,000 | +9.9% | 53,773 | +15.2% | 0.00% | – |
| Q4 2016 | $324,000 | -23.9% | 46,682 | +2.2% | 0.00% | -100.0% |
| Q3 2016 | $426,000 | 0.0% | 45,691 | -0.9% | 0.00% | 0.0% |
| Q2 2016 | $426,000 | +0.7% | 46,083 | -6.1% | 0.00% | – |
| Q1 2016 | $423,000 | +29.0% | 49,061 | +0.4% | 0.00% | – |
| Q4 2015 | $328,000 | +18.4% | 48,849 | +2.3% | 0.00% | – |
| Q3 2015 | $277,000 | -28.1% | 47,765 | +1.3% | 0.00% | – |
| Q2 2015 | $385,000 | +15.6% | 47,153 | +15.6% | 0.00% | – |
| Q1 2015 | $333,000 | -7.2% | 40,804 | +4.2% | 0.00% | -100.0% |
| Q4 2014 | $359,000 | -6.5% | 39,178 | +0.4% | 0.00% | 0.0% |
| Q3 2014 | $384,000 | -7.9% | 39,025 | +1.1% | 0.00% | 0.0% |
| Q2 2014 | $417,000 | – | 38,618 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 648,800 | $1,920,000 | 1.55% |
| Round Table Services, LLC | 339,391 | $998,000 | 0.31% |
| ARK Investment Management | 3,955,017 | $11,628,000 | 0.29% |
| Nikko Asset Management Americas, Inc. | 4,884,100 | $14,359,000 | 0.28% |
| WASATCH ADVISORS LP | 6,735,726 | $19,803,000 | 0.19% |
| Cedar Brook Financial Partners, LLC | 41,500 | $122,000 | 0.06% |
| Unified Trust Company, N.A. | 15,716 | $46,000 | 0.03% |
| Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors | 13,500 | $40,000 | 0.03% |
| STONERIDGE INVESTMENT PARTNERS LLC | 16,914 | $50,000 | 0.02% |
| Sumitomo Mitsui Trust Holdings, Inc. | 4,884,100 | $14,359,000 | 0.01% |